Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease
Testing for kidney disease is routine in clinical practice. This review focuses on advances in clinical evaluation of the glomerular filtration rate and albuminuria and their use in detecting acute and chronic kidney disease, designing trials of disease progression, and predicting risk in clinical p...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2022-06, Vol.386 (22), p.2120-2128 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2128 |
---|---|
container_issue | 22 |
container_start_page | 2120 |
container_title | The New England journal of medicine |
container_volume | 386 |
creator | Levey, Andrew S. Grams, Morgan E. Inker, Lesley A. |
description | Testing for kidney disease is routine in clinical practice. This review focuses on advances in clinical evaluation of the glomerular filtration rate and albuminuria and their use in detecting acute and chronic kidney disease, designing trials of disease progression, and predicting risk in clinical practice. |
doi_str_mv | 10.1056/NEJMra2201153 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2672327010</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2672363846</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-fc824f033015522020824e948fd7f5b578718d87775a2e83597a42efd47a6cfb3</originalsourceid><addsrcrecordid>eNp10NtLwzAUBvAgipvTR18lIIIv1Vyb9HHMbV6mgrjnkrYn2NGLJquw_95op6BgHhIO-fFx-BA6puSCEhlfPkxv751hjFAq-Q4ahptHQpB4Fw0JYToSKuEDdOD9ioRDRbKPBlzGQisihmi69OBxa_F89oRNU-BxlXV12XSuNHgB71DhssHjvFvD1_fkxbVNmeO7smhgg69KD8bDIdqzpvJwtH1HaDmbPk-uo8Xj_GYyXkS5oGod2VwzYQnnhEoZVmYkzJAIbQtlZSaVVlQXWiklDQPNZaKMYGALoUyc24yP0Hmf--ratw78Oq1Ln0NVmQbazqcsVowzRSgJ9PQPXbWda8J2vYq5FnFQUa9y13rvwKavrqyN26SUpJ_9pr_6Df5km9plNRQ_-rvQAM56UNc-bWBV_xP0ATZ4fSM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2672363846</pqid></control><display><type>article</type><title>Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>New England Journal of Medicine</source><creator>Levey, Andrew S. ; Grams, Morgan E. ; Inker, Lesley A.</creator><contributor>Ingelfinger, Julie R.</contributor><creatorcontrib>Levey, Andrew S. ; Grams, Morgan E. ; Inker, Lesley A. ; Ingelfinger, Julie R.</creatorcontrib><description>Testing for kidney disease is routine in clinical practice. This review focuses on advances in clinical evaluation of the glomerular filtration rate and albuminuria and their use in detecting acute and chronic kidney disease, designing trials of disease progression, and predicting risk in clinical practice.</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMra2201153</identifier><identifier>PMID: 35648704</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Accuracy ; Cardiovascular disease ; Chronic illnesses ; Chronic Kidney Disease ; Clinical Medicine ; Clinical Medicine General ; Clinical trials ; Creatinine ; Diabetes ; Glomerular filtration rate ; Hypertension ; Kidney diseases ; Nephrology ; Proteins ; Reimbursement ; Risk factors ; Urine</subject><ispartof>The New England journal of medicine, 2022-06, Vol.386 (22), p.2120-2128</ispartof><rights>Copyright © 2022 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-fc824f033015522020824e948fd7f5b578718d87775a2e83597a42efd47a6cfb3</citedby><cites>FETCH-LOGICAL-c417t-fc824f033015522020824e948fd7f5b578718d87775a2e83597a42efd47a6cfb3</cites><orcidid>0000-0003-2820-9482</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMra2201153$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMra2201153$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35648704$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Ingelfinger, Julie R.</contributor><creatorcontrib>Levey, Andrew S.</creatorcontrib><creatorcontrib>Grams, Morgan E.</creatorcontrib><creatorcontrib>Inker, Lesley A.</creatorcontrib><title>Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Testing for kidney disease is routine in clinical practice. This review focuses on advances in clinical evaluation of the glomerular filtration rate and albuminuria and their use in detecting acute and chronic kidney disease, designing trials of disease progression, and predicting risk in clinical practice.</description><subject>Accuracy</subject><subject>Cardiovascular disease</subject><subject>Chronic illnesses</subject><subject>Chronic Kidney Disease</subject><subject>Clinical Medicine</subject><subject>Clinical Medicine General</subject><subject>Clinical trials</subject><subject>Creatinine</subject><subject>Diabetes</subject><subject>Glomerular filtration rate</subject><subject>Hypertension</subject><subject>Kidney diseases</subject><subject>Nephrology</subject><subject>Proteins</subject><subject>Reimbursement</subject><subject>Risk factors</subject><subject>Urine</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp10NtLwzAUBvAgipvTR18lIIIv1Vyb9HHMbV6mgrjnkrYn2NGLJquw_95op6BgHhIO-fFx-BA6puSCEhlfPkxv751hjFAq-Q4ahptHQpB4Fw0JYToSKuEDdOD9ioRDRbKPBlzGQisihmi69OBxa_F89oRNU-BxlXV12XSuNHgB71DhssHjvFvD1_fkxbVNmeO7smhgg69KD8bDIdqzpvJwtH1HaDmbPk-uo8Xj_GYyXkS5oGod2VwzYQnnhEoZVmYkzJAIbQtlZSaVVlQXWiklDQPNZaKMYGALoUyc24yP0Hmf--ratw78Oq1Ln0NVmQbazqcsVowzRSgJ9PQPXbWda8J2vYq5FnFQUa9y13rvwKavrqyN26SUpJ_9pr_6Df5km9plNRQ_-rvQAM56UNc-bWBV_xP0ATZ4fSM</recordid><startdate>20220602</startdate><enddate>20220602</enddate><creator>Levey, Andrew S.</creator><creator>Grams, Morgan E.</creator><creator>Inker, Lesley A.</creator><general>Massachusetts Medical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2820-9482</orcidid></search><sort><creationdate>20220602</creationdate><title>Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease</title><author>Levey, Andrew S. ; Grams, Morgan E. ; Inker, Lesley A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-fc824f033015522020824e948fd7f5b578718d87775a2e83597a42efd47a6cfb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Accuracy</topic><topic>Cardiovascular disease</topic><topic>Chronic illnesses</topic><topic>Chronic Kidney Disease</topic><topic>Clinical Medicine</topic><topic>Clinical Medicine General</topic><topic>Clinical trials</topic><topic>Creatinine</topic><topic>Diabetes</topic><topic>Glomerular filtration rate</topic><topic>Hypertension</topic><topic>Kidney diseases</topic><topic>Nephrology</topic><topic>Proteins</topic><topic>Reimbursement</topic><topic>Risk factors</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Levey, Andrew S.</creatorcontrib><creatorcontrib>Grams, Morgan E.</creatorcontrib><creatorcontrib>Inker, Lesley A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Levey, Andrew S.</au><au>Grams, Morgan E.</au><au>Inker, Lesley A.</au><au>Ingelfinger, Julie R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2022-06-02</date><risdate>2022</risdate><volume>386</volume><issue>22</issue><spage>2120</spage><epage>2128</epage><pages>2120-2128</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>Testing for kidney disease is routine in clinical practice. This review focuses on advances in clinical evaluation of the glomerular filtration rate and albuminuria and their use in detecting acute and chronic kidney disease, designing trials of disease progression, and predicting risk in clinical practice.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>35648704</pmid><doi>10.1056/NEJMra2201153</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-2820-9482</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-4793 |
ispartof | The New England journal of medicine, 2022-06, Vol.386 (22), p.2120-2128 |
issn | 0028-4793 1533-4406 |
language | eng |
recordid | cdi_proquest_miscellaneous_2672327010 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; New England Journal of Medicine |
subjects | Accuracy Cardiovascular disease Chronic illnesses Chronic Kidney Disease Clinical Medicine Clinical Medicine General Clinical trials Creatinine Diabetes Glomerular filtration rate Hypertension Kidney diseases Nephrology Proteins Reimbursement Risk factors Urine |
title | Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T23%3A08%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uses%20of%20GFR%20and%20Albuminuria%20Level%20in%20Acute%20and%20Chronic%20Kidney%20Disease&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Levey,%20Andrew%20S.&rft.date=2022-06-02&rft.volume=386&rft.issue=22&rft.spage=2120&rft.epage=2128&rft.pages=2120-2128&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMra2201153&rft_dat=%3Cproquest_cross%3E2672363846%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2672363846&rft_id=info:pmid/35648704&rfr_iscdi=true |